UK markets open in 42 minutes

MedAvail Holdings, Inc. (73M.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-11.7700 (-100.00%)
As of 08:05AM CEST. Market open.
Currency in

Valuation measures4

Market cap (intra-day) 1.73M
Enterprise value -9.56M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.48
Price/book (mrq)0.87
Enterprise value/revenue -0.22
Enterprise value/EBITDA 0.20

Trading information

Stock price history

Beta (5Y monthly) -106.77
52-week change 3-31.14%
S&P500 52-week change 326.27%
52-week high 317.7250
52-week low 36.8400
50-day moving average 311.7750
200-day moving average 311.5801

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.61M
Implied shares outstanding 61.61M
Float 8406.67k
% held by insiders 10.40%
% held by institutions 183.95%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 301 Aug 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin -106.17%
Operating margin (ttm)-1,099.75%

Management effectiveness

Return on assets (ttm)-68.15%
Return on equity (ttm)-194.67%

Income statement

Revenue (ttm)43.33M
Revenue per share (ttm)26.19
Quarterly revenue growth (yoy)-25.40%
Gross profit (ttm)N/A
EBITDA -40.52M
Net income avi to common (ttm)-54.34M
Diluted EPS (ttm)-33.5600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.36M
Total cash per share (mrq)8.9
Total debt (mrq)2.26M
Total debt/equity (mrq)9.82%
Current ratio (mrq)6.51
Book value per share (mrq)14.28

Cash flow statement

Operating cash flow (ttm)-31.54M
Levered free cash flow (ttm)-27.09M